Screener / SEC EDGAR /CIK 0001388658 /10-K filed Feb 19, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Instruments

iRhythm Holdings, Inc. IRTC

Compare with peers Embed
Why it changed

The biggest changes in the 10-K filed Feb 19, 2026, in management's words

10-K, Item 7

This fiscal year against the last, and the sentences in the MD&A where management explains each change. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Cash from operations

Big change, FY to Dec 31, 2025 vs Dec 31, 2024

+2285.3%

“Cash provided by operating activities increased by $77.5 million, primarily due to reductions in our net loss driven by our revenue growth, timing of cash collections associated with our accounts receivable, and timing of accruals and payments associated with our accrued compensation and third-party vendor expenditures within our accrued liabilities.”

Read it in the 10-K

“These increases in cash provided by operating activities were offset by increases to inventory and prepaid expenses and other current assets, supporting growth in our operations and securing additional inventory stock.”

Read it in the 10-K

Operating margin

Big change, FY to Dec 31, 2025 vs Dec 31, 2024

-19.5% to -7.7% (+11.8 pts)

“The increase in selling, general and administrative expenses was primarily attributable to increases in headcount-related costs (including stock-based compensation), legal and professional fees, provisions for credit losses, and claims processing fees.”

Read it in the 10-K

Revenue

Big change, FY to Dec 31, 2025 vs Dec 31, 2024

+26.2%

“We receive revenue for our iRhythm Services primarily from third-party payors, which include contracted third-party payors and CMS.”

Read it in the 10-K

“Offsetting the revenue growth from volume and product mix were higher contractual allowance reserves recognized during the year ended December 31, 2025, as compared to the year ended December 31, 2024, resulting from higher payer claims denials from revenue growth associated with our contracted third-party payors and CMS.”

Read it in the 10-K

Gross margin

Big change, FY to Dec 31, 2025 vs Dec 31, 2024

68.9% to 70.6% (+1.7 pts)

“The majority of our increase in cost of revenue is due to increases in headcount, component costs (inclusive of tariffs), and amortization costs related to Zio monitor and Zio AT PCBAs.”

Read it in the 10-K

What management said, year by year

The cause given in each 10-K, 2 fiscal years, newest first · MD&A (Item 7)

Each bar is how the line changed that year (from the same 10-K's XBRL). Under it, the sentence in that year's MD&A that names the line, a direction and a cause, word for word. A year with no sentence says so.

Revenue

2 of 2 years explained
  • FY 2025 +26.2%

    “We receive revenue for our iRhythm Services primarily from third-party payors, which include contracted third-party payors and CMS.”

    Read it in the FY 2025 10-K

    “Offsetting the revenue growth from volume and product mix were higher contractual allowance reserves recognized during the year ended December 31, 2025, as compared to the year ended December 31, 2024, resulting from higher payer claims denials from revenue growth associated with our contracted third-party payors and CMS.”

    Read it in the FY 2025 10-K
  • FY 2024 +20.1%

    “We receive revenue for the Zio Services primarily from third-party payors, which include contracted third-party payors and CMS.”

    Read it in the FY 2024 10-K

    “We earn revenue from the provision of our Zio Services primarily from contracted third-party payors, CMS, and healthcare institutions.”

    Read it in the FY 2024 10-K

Gross margin

2 of 2 years explained
  • FY 2025 +1.7 pts

    “The majority of our increase in cost of revenue is due to increases in headcount, component costs (inclusive of tariffs), and amortization costs related to Zio monitor and Zio AT PCBAs.”

    Read it in the FY 2025 10-K
  • FY 2024 +1.5 pts

    “The increase in cost of revenue was primarily due to increases in headcount-related costs associated with the increase in volume of Zio Services.”

    Read it in the FY 2024 10-K

Operating margin

1 of 2 years explained
  • FY 2025 +11.8 pts

    “The increase in selling, general and administrative expenses was primarily attributable to increases in headcount-related costs (including stock-based compensation), legal and professional fees, provisions for credit losses, and claims processing fees.”

    Read it in the FY 2025 10-K
  • FY 2024 +5.9 pts

    The FY 2024 MD&A has no sentence that names a cause for this change.

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K

Sources

The Management's Discussion and Analysis (Item 7) of the latest 10-K, quoted word for word; the changes are computed from the same 10-K's XBRL.

Also

Financials: the numbers year by year.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IRTC/export.csv") into a cell.

Next:Accounting checks
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.